Bharat Biotech was established in the year 1996 by Dr. Krishna M. Ella and Mrs. Suchitra K. Ella, with a vision to generate innovative technologies, along with a strong backbone of intellectual capital for the manufacturing of unique vaccines and biotherapeutics. Today, Bharat Biotech is a multidimensional biotechnology company specializing in product-oriented research and development leading to the manufacture of vaccines and biotherapeutics with global IPR’s associated to its products.
Dr. Krishna M. Ella & Mrs. Suchitra Ella founded Bharat Biotech in Genome Valley, Hyderabad, India.
Dr. A.P.J Abdul Kalam launches Hepatitis B Vaccine – Revac-B+®; Bharat Biotech pioneers the World’s First Cesium Chloride Free Hepatitis B vaccine.
The Company expands facility, to make 100 million doses of Hepatitis B vaccine (Revac-B) annually, from eight million doses – to become the largest manufacturers of Hepatitis B vaccines in the world.
International Centre for Genetic Engineering and Biotechnology (ICGEB) and Bill & Melinda Gates Foundation selects Bharat Biotech as one of their inclusions in the Malaria Vaccine Initiative.
Chandrababu Naidu, former CM launches India’s first Probiotic Yeast – BIOGIT®, and Bharat Biotech’s first Bio-therapeutic product.
Bharat Biotech, the first Indian Company to receive two grants from the Bill & Melinda Gates Foundation through PATH to develop new vaccines against Malaria and Rotavirus.
Father of Polysaccharide Vaccines, Dr. John B. Robbins was felicitated by Bharat Biotech for his tremendous contribution to the world of vaccines.
Bharat Biotech pioneers India’s First Recombinant Human Epidermal Growth Factors for I & II degree burns, skin grafts, and diabetic foot ulcers – REGEN-D®. And simultaneously launched it’s 2nd Biotherapeutic product, ZELECT® – Oral Rehydration Salts.
The Company announces a manufacturing and marketing agreement with Cambridge-based Acambis, plc., for developing Japanese Encephalitis vaccine – a neglected disease.
Dr Julie Gerberding, Director, Centre for Disease Control and Prevention (CDC) launched the chromatographically purified vero cell rabies vaccine, INDIRAB® (then Rabirix®).
The Company launches BioHib®, India’s first indigenously developed and manufactured Haemophilus Influenza type B (Hib) vaccine
Dr. Manmohan Singh, Hon’ble Prime Minister of India presents FICCI Award by the Federation of Indian Chambers of Commerce and Industry for “Excellence in Science, Technology and Technological Innovation”.
Comvac 5 PFS® (Pre-Filled Syringes) – Pentavalent Combination vaccine – Bharat Biotech’s best-selling product was launched by Senior General Mr. Than Shwe, Chairman, State Peace & Development Council, Union of Myanmar.
Bharat Biotech launched HNVAC® – India’s first cell culture-based H1N1 (Human Inactivated Influenza A virus) Swine flu Vaccine.
Bill Gates, co-chair of the Bill & Melinda Gates Foundation and Chairman of Microsoft, meets Dr. Krishna Ella, CMD of Bharat Biotech, regarding developement of RotavacTM – Bharat Biotech’s affordable diarrheal vaccine.
Bharat Biotech & University of Maryland collaboratively received USD 4 Million ‘Strategic Translation Award’ from the Wellcome Trust for clinical development of a new life-saving conjugate vaccine for Invasive Non-Typhoidal Salmonella (iNTS).
The Company launches Typabar TCV®. – is the world’s 1st clinically proven conjugate Typhoid vaccine.
The Company launches JENVAC®- is safe and highly effective vaccine that protects against all the known strains of Japanese encephalitis.